Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.87
+0.05 (0.86%)
Oct 6, 2026, 10:56 AM EDT - Market open
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $542.73 million as of October 6, 2026. Its market cap has decreased by -45.92% in one year.
Market Cap
542.73M
Enterprise Value
642.16M
1-Year Change
-45.92%
Ranking
Category
Stock Price
$5.87
ChartMarket Cap Chart
Since the IPO on May 6, 2021, Valneva SE's market cap has decreased from $1.29B to $542.73M, a decrease of -58.01%. That is a compound annual growth rate of -14.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 542.73M | -28.04% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 126.51% |
| May 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 560.42M |
| CytomX Therapeutics | 557.82M |
| Phathom Pharmaceuticals | 549.66M |
| MapLight Therapeutics | 545.75M |
| Oculis Holding AG | 538.92M |
| Altimmune | 532.01M |
| Prime Medicine | 530.15M |
| Monopar Therapeutics | 523.35M |